@Liberteur @GidMK @DanielGriffinMD Whoops; *six* citations (once I actually clicked through to see what they were)... all cited in articles from new, minor, and/or unknown journals, with the exception of being included in the most-recent Cochrane Review: h
@gmeeus2 @AlectheLad @MrDarcy1815 @K_Sheldrick @travis_view Actual proper meta-analysis simply shows that it’s not effective when properly run studies are referenced. https://t.co/oteh8I7TLv And second, the onus has been on you to prove that they -are- e
@Stephen55857391 @SallySamsara @alexandrosM @GidMK @sTeamTraen @K_Sheldrick @jamesheathers You mean the Cochrane meta-analysis which concluded the current evidence for ivermectin is weak? https://t.co/dXj95Jor52
@CallTheRN I think the best rebuttal of that Bryant meta-analysis is that included low quality studies and all the mortality benefit came from one fraudulent study (Elegazzar) which is now withdrawn. I’d refer to the gold standard🥇 Cochrane meta-analysis
@OHTRTA Do you have an updated chart? Most of the data from Egypt and Peru is fraudulent and has been retracted. Most of the other data isn't IVM vs placebo but and aren't randomized or controlled. https://t.co/2QLtbXsjq2
RT @Cochrane_IDG: New #Cochrane review shows no demonstrable benefit of #ivermectin against #Covid-19 https://t.co/QOY7IVQ0Xg @Cochrane_I…
RT @CochraneJapan: 新型コロナウイルス感染症 (COVID-19) の予防および治療に対するイベルメクチン https://t.co/nL80QRC1rf
@JenniG65103034 @NevgiAnne @IinaMaki @Pee_Ranta @lasleh @iltasanomat Kannattaa katsoa systemaattinen Cochrane-katsaus aiheesta https://t.co/QDC78jnDAt
@drsusanshaw Respectfully, according to a Cochrane review dated July 28 2021, the science seems mixed and uncertain. https://t.co/mRucNWDQzT
RT @CochraneJapan: 新型コロナウイルス感染症 (COVID-19) の予防および治療に対するイベルメクチン https://t.co/nL80QRC1rf
@soraya32990507 @jaaprog1 @RonaldOverbosch @IedemaEls Literatuur lezen en interpreteren is lastig. Er zijn veel studies van lage kwaliteit. Cochrane (de baas-boven-baas) van meta-analyses en reviews heeft er naar gekeken en concludeert: geen bewijs. htt
@psonners @nickskies @DocOnSkis @stefoons @YouAreLobbyLud If you’d like to see how clinicians assess the literature, worthwhile looking at the Cochrane Collaboration. Independent, rigorous, standardised methodology of analysis- it’s considerably more than
Might try another poll at some point... https://t.co/x0vAskg1O7 https://t.co/BlaXLUVp3l https://t.co/cZipkQVKmM
@DataInforms @SamHarrisOrg @BretWeinstein @joerogan You're welcome to check out the analyses it directly cites. https://t.co/G37tHLfPXe https://t.co/jzgMZeJPes "stopped for futility"
まだまだだと。
RT @CochraneJapan: 新型コロナウイルス感染症 (COVID-19) の予防および治療に対するイベルメクチン https://t.co/nL80QRC1rf
まあ、ほぼ分かっていない。
RT @CochraneJapan: 新型コロナウイルス感染症 (COVID-19) の予防および治療に対するイベルメクチン https://t.co/nL80QRC1rf
イベルメクチンぇ…
RT @CochraneJapan: 新型コロナウイルス感染症 (COVID-19) の予防および治療に対するイベルメクチン https://t.co/nL80QRC1rf
新型コロナウイルス感染症 (COVID-19) の予防および治療に対するイベルメクチン https://t.co/nL80QRC1rf
@moreandr Вот почитайте то чему доверяет весь научный мир https://t.co/WjPZFIkExd
#Samaha et al RCT #ivermectin published 26 May 2021 #retraction Samaha cited in: Cruciani et al, Italy meta-analysis, Publ 8 September 2021 https://t.co/G0a4ou5Knt and Popp et al, Germany Cochrane meta-analysis, Publ 28 July 2021 https://t.co/W76f6aHW
RT @CochraneLibrary: JUST PUBLISHED - #Ivermectin for preventing and treating #COVID19 https://t.co/FR6Lc5HB7J New @Cochrane_IDG looked at…
RT @CochraneLibrary: JUST PUBLISHED - #Ivermectin for preventing and treating #COVID19 https://t.co/FR6Lc5HB7J New @Cochrane_IDG looked at…
@LarryBurkCEHP @ChemistryatYork There is no strong scientific evidence to support the use of Ivermectin, other than in clinical trials to gain further evidence. https://t.co/O95TtacTo5
@teejjohannesson @AndrewLawton For ivermectin, there is no good evidence to back up any recommendations for this. Most importantly if we do want to get out of this fully (2) vax is clearly the ticket. Alberta vs ontario shows this clear as day. Heres a sum
RT @S96405539: 【補足】参考までに、“イベルメクチンの新型コロナウイルス感染症に対する安全性/有効性”に関して現時点で得られる最良のエビデンスの一つは、コクランレビューでしょう。 医師であれば、このエビデンスを踏まえた上で患者さんへ治療法や予防法を提案する必要が…
@prolitissident This pub med place pulls up all of the studies. Good and bad. So there’s others to look at. Watch out for confirmation bias. https://t.co/SDaV8rAFSR
@uninspectator @HedShodd @I_Just_Zap_Em @jarl_marx @cminnis215 @jamesdpitley @49ER415ER @TalibandofBros @hasanthehun https://t.co/tsxyIWdRDf cochrane analysis of the RCTs
@uninspectator @HedShodd @I_Just_Zap_Em @jarl_marx @cminnis215 @jamesdpitley @49ER415ER @TalibandofBros @hasanthehun We already did and those studies have been published. Ivermectin is not effective in treating or preventing covid. https://t.co/tsxyIWvsuN
@ACGalarza @lximenezfyvie @Antichayote221 https://t.co/nVFLZ34SIe Esta es una revision de Cochrane bastante sencilla
RT @S96405539: 【補足】参考までに、“イベルメクチンの新型コロナウイルス感染症に対する安全性/有効性”に関して現時点で得られる最良のエビデンスの一つは、コクランレビューでしょう。 医師であれば、このエビデンスを踏まえた上で患者さんへ治療法や予防法を提案する必要が…
RT @MuriahUmoquit: #infodemic and #misinformation and #fakenews, oh my! 😩#scicomm during a #pandemic is stressful -- but there is help!…
@baggers951 @richardemoe @louisaclary @Krishna54158015 @TFR94504381 @chasbarter @SeivwrightTrudy @jjchamie @Covid19Crusher @tlowdon I'm not at all - I've used it for parasites and I'd love it if was effective in Brazil and India for covid - it just isn't,
@DeanForTruth sadly, no: https://t.co/93ZY5r0T7S
@millard_jeff @kcrnicu these are the good ones: https://t.co/93ZY5r0T7S
@AdamDJTbrand @AnnastaciaMP Saving Children, have you looked at the figures, fear is no excuse to not do some reading.https://t.co/N3TipynEYo Available data suggest that one-third of SARS-CoV-2 infections remain asymptomatic (Oran 2021). About 80% of symp
RT @MuriahUmoquit: #infodemic and #misinformation and #fakenews, oh my! 😩#scicomm during a #pandemic is stressful -- but there is help!…
RT @MuriahUmoquit: #infodemic and #misinformation and #fakenews, oh my! 😩#scicomm during a #pandemic is stressful -- but there is help!…
RT @MuriahUmoquit: #infodemic and #misinformation and #fakenews, oh my! 😩#scicomm during a #pandemic is stressful -- but there is help!…
Even though Dr. Hill left, I hope people still get something out of his insightful analysis and honesty on ivermectin: https://t.co/OlpHvWbFV0 https://t.co/kFXoh0I9S9 https://t.co/fzWBUqs0jX https://t.co/ZQe6Tt8ZjS
@__Hazo__ @ColmanGc @MaajidNawaz This is a German Ivermectin study. They looked at literally hundreds of studies. https://t.co/KoXLwrmQnA
@hasselhofnot In vitro...it means in a lab culture. It does not mean in a living creature. For that you need in vivo and according to Cochrane the most trusted source, there is no benefit. https://t.co/Hde7Svp7EP
@Phil74010610 @stylewar @PierreKory Cochrane is the gold standard of meta analysis. They are tip top of the chain of credibility in evaluating studies. There is no higher authority. Period. https://t.co/a621eT7KwS
@Phil74010610 @betbrett @stylewar @PierreKory Here's another, summarizing some of the problems with those "40+" studies: https://t.co/RZ9vZzHnbG
#invermectin doesn't cure #COVID19
@RWMaloneMD Evidence for ivermectin remains lacking at this time: https://t.co/xrB6ZAFbal
RT @MuriahUmoquit: #infodemic and #misinformation and #fakenews, oh my! 😩#scicomm during a #pandemic is stressful -- but there is help!…
@isfies666 @ephraim_ki @dokhollidays @Karl_Lauterbach Zum Glück gibts für sowas keine dubiosen Threads sondern Cochrane reviews: ‘Overall, the reliable evidence available does not support the use of ivermectin for treatment or prevention of COVID‐19 outsi
#infodemic and #misinformation and #fakenews, oh my! 😩#scicomm during a #pandemic is stressful -- but there is help! ➡️Join this FREE @WorldEBHCDay panel discussion (with @jacknunn!) for #WorldEBHCDay https://t.co/YhwixmryhB
@TheBreakdownAB @TrishEstabrooks @EPSB Sherry Adams After reviewing 14 studies on Ivermectin: https://t.co/UFcTJUTPjJ “Based on the current very low- to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or p
@cspotweet After reviewing 14 studies on Ivermectin: https://t.co/UFcTJUTPjJ “Based on the current very low- to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19.”
@JasonPYYC After reviewing 14 studies on Ivermectin: https://t.co/UFcTJUTPjJ “Based on the current very low- to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19.”
@Mooshedmellow @GidMK @alexandrosM "Overall, the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials." https://t.co/9M8djQtXCC https://t.co/opU7KIKFH8
@BoSaibot @Fischblog @ZJasko Das sind Screenshots, keine Beweise. Wie wärs mit einer unabhängigen Studie? Z.B. sowas: https://t.co/oWd52zu7o7
RT @RayTaylorUK: @millard_jeff @kcrnicu Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb…
@GratefulDina @ZDoggMD Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Oxford:
@GinsbergHarold @TGAgovau Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Oxfo
@bskinnerwv @OhioCapJournal Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Ox
@picc_anthony India drop was due to high attack rate and restrictions. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Oxford: https://t.co/93ZY5qJigk
@bansheesmoon Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Oxford: https://
@arifanwar Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Oxford: https://t.c
@Annie291201763 @h29909947 @PraireLady @JustJess020786 Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review from Oxford: https://t.co/93ZY5qJigk
@BrianMGreen @NutsaboutGuts @LisaLaFond2 @JackPosobiec @pfizer Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@boydscott Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@kwwawwk Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@RobertS25532163 Fluvoxamine looks more hopeful Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@estebangerbasi Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5
@v_hermien @702Gaming @millard_jeff @kcrnicu Fluvoxamine looks more hopeful Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@Sundog5274 Fluvoxamine looks more hopeful Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@KatieBeeNV Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJig
@anne_agreig Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJi
@nytimes Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@CaseIsCapped @samanthamarika1 Fluvoxamine looks more hopeful Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@dunvirkin Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@nikk_tastic Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJi
@Michele91500774 @RMConservative @FoxNews @FoxBusiness @Merck Fluvoxamine looks more hopeful for low cost repurposed drug. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic
@NOLAnews Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@ThomasJ14681258 @doctorderision Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: h
@cravecreative Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5q
@Independent Fluvoxamine looks more hopeful. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@NYDailyNews Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJi
@BLNewsMedia Whole cities of people took ivermectin in Brazil, very interesting results: https://t.co/Uqew8k0POb Robust high quality systematic review: https://t.co/93ZY5qJigk
@parshalltalk Fluvoxamine looks more hopeful, and Molnupavir or Regeneron for early treatment. Robust high quality systematic review: https://t.co/93ZY5qJigk